Sep 16 |
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
|
Sep 14 |
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five years
|
Aug 9 |
InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript
|
Aug 7 |
Companies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In Growth
|
Aug 6 |
InspireMD GAAP EPS of -$0.22, revenue of $1.74M
|
Aug 6 |
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
|
Aug 5 |
InspireMD Q2 2024 Earnings Preview
|
Aug 5 |
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
|
Jul 30 |
InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th
|
Jul 1 |
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
|